Integrating T cell signaling and metabolism to enhance T cell engager responses in solid tumors
Frontiers in Immunology · 22.07.2026 · 17
DOI: 10.3389/fimmu.2026.1887842 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 22.07.2026. Verfasst von Michael Scaglione und 5 weiteren Autor:innen. Beteiligte Einrichtung: Amgen R&D Postdoctoral Fellows Program, South San Francisco, CA, United States. Hauptthemen laut MEDLINE: Neoplasms, Signal Transduction, T-Lymphocytes. Die Arbeit nennt 278 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen.
Abstract (Originalsprache)
T cell engagers (TCEs) have delivered meaningful clinical benefit to patients, with eight molecules currently FDA-approved for hematologic malignancies and two approved for solid tumor indications. Despite their transformative potential, successful TCE development across solid tumor indications remains challenging, and additional strategies are needed to maintain T cell fitness and function within the tumor microenvironment (TME). Next-generation TCE designs aim to increase response rate and bolster durability by optimizing or delivering additional signals to T cells. In recent years, cellular metabolism has emerged as a potent regulator of T cell function and fate, shaping immunity by supporting the biochemical requirements of immunological effector functions and acting as a direct immunoregulatory signal from the TME itself. Despite this, neither cell-intrinsic nor environmental roles for metabolism in regulating TCE responses in solid tumors have been explicitly explored. We propose that metabolism is a powerful lens for understanding TCE efficacy and resistance in solid tumors, integrating signals from both surface receptors and the biochemical environment of the TME to shape T cell function and therapeutic response. In this mini-review, we highlight how three classical T cell signaling axes - 1) the T cell receptor complex, 2) costimulatory receptors, and 3) cytokine receptors – drive metabolic rewiring to license immune function and shape T cell fate. We also explore how environmental cues such as nutrients or metabolic stressors govern T cell responses, highlighting how biochemical perturbations within the TME could hamper TCE efficacy. Finally, we highlight emerging methods for dissecting metabolic contributions to TCE responses, proposing that understanding the interplay between immunological signaling, cellular metabolism, and immune programming could inform the design of next-generation TCEs for solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amgen R&D Postdoctoral Fellows Program, South San Francisco, CA, United States.
Förderung
- Amgen
Zitieren
APA
Scaglione, M., Engavale, M., Chun, M. G., Sawant, D. V., Lu, D. R., & LaGory, E. (2026). Integrating T cell signaling and metabolism to enhance T cell engager responses in solid tumors. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1887842
Vancouver
Scaglione M, Engavale M, Chun MG, Sawant DV, Lu DR, LaGory E. Integrating T cell signaling and metabolism to enhance T cell engager responses in solid tumors. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1887842
BibTeX
@article{Scaglione2026,
author = {Scaglione, Michael and Engavale, Minal and Chun, Matthew G and Sawant, Deepali V and Lu, Daniel R and LaGory, Edward},
title = {Integrating T cell signaling and metabolism to enhance T cell engager responses in solid tumors},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1887842}
}
EUVIMED